substance p has been researched along with B16 Melanoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feng, BN; Gao, YY; Geng, KK; Liu, L; Ping, FF; Zhou, J | 1 |
Ping, F; Shang, J; Song, J; Zhang, L; Zhou, J | 1 |
Lester, BR; Sun, Z; Wilcox, GL; Wu, HH | 1 |
3 other study(ies) available for substance p and B16 Melanoma
Article | Year |
---|---|
Cross-talk between 5-hydroxytryptamine and substance P in the melanogensis and apoptosis of B16F10 melanoma cells.
Topics: Animals; Apoptosis; Cell Line, Tumor; Melanins; Melanoma, Experimental; Mice; Monophenol Monooxygenase; Receptor, Serotonin, 5-HT2A; Receptors, Neurokinin-1; Serotonin; Stress, Physiological; Substance P | 2016 |
Activation of neurokinin-1 receptor by substance P inhibits melanogenesis in B16-F10 melanoma cells.
Topics: Animals; Cell Line, Tumor; Cell Survival; Extracellular Signal-Regulated MAP Kinases; Intramolecular Oxidoreductases; Melanins; Melanoma, Experimental; Membrane Glycoproteins; Mice; Microphthalmia-Associated Transcription Factor; Monophenol Monooxygenase; Neurokinin-1 Receptor Antagonists; Oxidoreductases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Processing, Post-Translational; Receptors, Neurokinin-1; Substance P | 2012 |
Antinociception following implantation of mouse B16 melanoma cells in mouse and rat spinal cord.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brimonidine Tartrate; Catecholamines; Cell Transplantation; Desipramine; Dioxanes; Idazoxan; Injections, Spinal; Male; Melanoma, Experimental; Mice; Mice, Inbred ICR; Morphine; Naloxone; Neoplasm Transplantation; Nociceptors; Pain Threshold; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Spinal Cord; Substance P; Transplantation, Heterotopic | 1994 |